Efficacy and safety of cotadutide, a dual glucagon‐like peptide‐1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease

AIM: To assess the efficacy, safety and tolerability of cotadutide in patients with type 2 diabetes mellitus and chronic kidney disease. MATERIALS AND METHODS: In this phase 2a study (NCT03550378), patients with body mass index 25‐45 kg/m(2), estimated glomerular filtration rate 30‐59 ml/min/1.73 m(...

Descripción completa

Detalles Bibliográficos
Autores principales: Parker, Victoria E. R., Hoang, Thuong, Schlichthaar, Heike, Gibb, Fraser W., Wenzel, Barbara, Posch, Maximillian G., Rose, Ludger, Chang, Yi‐Ting, Petrone, Marcella, Hansen, Lars, Ambery, Philip, Jermutus, Lutz, Heerspink, Hiddo J. L., McCrimmon, Rory J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323481/
https://www.ncbi.nlm.nih.gov/pubmed/35403793
http://dx.doi.org/10.1111/dom.14712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323481/
https://www.ncbi.nlm.nih.gov/pubmed/35403793
http://dx.doi.org/10.1111/dom.14712

Ejemplares similares